Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jessica Jou

2PUBLICATIONS
11CO-AUTHORS
Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Aug 24, 2023
Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy.

Jessica Jou, Shumei Kato, Hirotaka Miyashita

|Oct 30, 2020
The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification.

Jessica Jou, Kevin J Harrington, Mai-Britt Zocca

Pageof 1

Frequent Collaborators

1 joint publications

Mai-Britt Zocca

1 joint publications

Shumei Kato

1 joint publications

Hirotaka Miyashita

1 joint publications

Kartheeswaran Thangathurai

1 joint publications

Sarabjot Pabla

1 joint publications

Paul DePietro

1 joint publications

Mary K Nesline

1 joint publications

Jeffrey M Conroy

1 joint publications

Eitan Rubin

1 joint publications

Ramez N Eskander

Frequent Collaborators

1 joint publications

Mai-Britt Zocca

1 joint publications

Shumei Kato

1 joint publications

Hirotaka Miyashita

1 joint publications

Kartheeswaran Thangathurai

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

2.7K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.9K
See more related videos

Top Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

2.7K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.9K
See more related videos